The Prevalence of Intolerance for Low-Dose Acetylsalicylacid in the Secondary Prevention of Atherothrombosis

European Journal of Vascular and Endovascular Surgery

Volumn 37, Issue 5, 2009, Pages 597-603

  Tournoij, E ^a   Peters, R J G ^b   Langenberg, M ^c   Kanhai, K J K ^d   Moll, F L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c sanofi aventis Netherlands ^*

^d Dept of Medical Research   (Netherlands)

Author keywords

Acetylsalicylic acid; Adverse effects; Platelet inhibition; Prevention; Questionnaire; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CARBASALATE CALCIUM;

ADULT; AGED; ANEMIA; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; BLOOD DISEASE; BRONCHOSPASM; CONSTIPATION; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DIARRHEA; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUODENUM ULCER; EPIGASTRIC BURNING; EPIGASTRIC DISCOMFORT; EPIGASTRIC PAIN; EPISTAXIS; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GENERAL PRACTITIONER; HUMAN; IMMUNOPATHOLOGY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RASH; RESPIRATORY TRACT DISEASE; RHINITIS; SKIN DISCOLORATION; STOMACH ULCER; THROMBOCYTOPENIA; URTICARIA; VOMITING;

ADMINISTRATION, ORAL; AGED; ANGIOEDEMA; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBOLISM, CHOLESTEROL; EXANTHEMA; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; MALE; NETHERLANDS; PLATELET AGGREGATION INHIBITORS; QUESTIONNAIRES; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; THROMBOCYTOPENIA;

EID: 64749115789     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.01.009     Document Type: Article

References (18)

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
2. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348 (1996) 1329-1339
3. Farrell B., Godwin J., Richards S., and Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54 (1991) 1044-1054
4. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 351 (1998) 233-241
5. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351 (1998) 1755-1762
6. Silagy C.A., McNeil J.J., Donnan G.A., Tonkin A.M., Worsam B., and Campion K. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 54 (1993) 84-89
7. Straus W.L., Ofman J.J., MacLean C., et al. Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions. Am J Gastroenterol 97 (2002) 1951-1958
8. Roderick P.J., Wilkes H.C., and Meade T.W. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 35 (1993) 219-226
9. Stevenson D.D., and Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118 (2006) 773-786 quiz 787-778
10. Hedman J., Kaprio J., Poussa T., and Nieminen M.M. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28 (1999) 717-722
11. Biondi-Zoccai G.G., Lotrionte M., Agostoni P., et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27 (2006) 2667-2674
12. Drossman D.A. The functional gastrointestinal disorders and the Rome II process. Gut 45 Suppl 2 (1999) II1-II5
13. Niv Y., Battler A., Abuksis G., Gal E., Sapoznikov B., and Vilkin A. Endoscopy in asymptomatic minidose aspirin consumers. Dig Dis Sci 50 (2005) 78-80
14. Bochenek G., Nizankowska E., and Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 51 (1996) 16-23
15. Szczeklik A. Mechanism of aspirin-induced asthma. Allergy 52 (1997) 613-619
16. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
17. Ng F.H., Wong B.C., Wong S.Y., Chen W.H., and Chang C.M. Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk-a single-blind, randomized controlled study. Aliment Pharmacol Ther 19 (2004) 359-365
18. Chan F.K., Ching J.Y., Hung L.C., et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 352 (2005) 238-244